So far in 2017 the National Institute on Health has awarded the University of Pittsburgh over $113M in research project grants. This funding supports 296 separate projects. The top six grants were awarded to the university’s School of Medicine.Read More
Science Market Update
Tags: University of Pittsburgh, Bioresearch funding, UPITT, NIH funded Research Projects, BioResearch Product Faire Event, Lab Product Sales, lab products, BioResearch Product Faire, Liver disease, NIH awards 2017, 2017 research funding, Xenograft study
(Article posted 2015 and updated in 2016)
Patients with a condition known as lung nodules may soon be breathing a bit more easily, thanks to research funding granted to the University of California, Davis and a new diagnostic technology tested in a 2016 study at the Morehouse School of Medicine and Emory University. Lung nodules are usually benign, small lesions often found in CT chest scans. While only 2% of these nodules end up being cancerous, they still require examination and monitoring to ensure the safety of the patient.Read More
Tags: CA, Emory University, University of California Davis, cancer research, California, Cancer, UCDMC, BioResearch Product Faire Event, Research Funding, Sacramento, Davis, UC Davis - Medical Center, research grants, lung cancer
According to the American Cancer Society, nearly 1 in 8 women will develop breast cancer in their lives, making it the second most common cancer for American women. However, breast cancer does not affect all women equally. Past studies have shown that women of African descent with breast cancer die at a higher rate than white women. Researchers at the University of Southern California Keck School of Medicine have received a grant of $12 million from the National Cancer Institute (NCI) to study the disparities in breast cancer in women.Read More
Blog updated on 6/14/2016.Read More
(Original article from 2013 by Jennifer Niuwkerk. Updated information added by Jennifer Winstead.)
Are you a researcher, lab manager, post-doc or purchasing agent interested in networking with colleagues and learning about the latest lab equipment and services on the market at the Universtity of California, Davis Medical Center?
UPDATE: If so, make sure you don’t miss Biotechnology Calendar, Inc.’s Sacramento BioResearch Product Faire™ Event on June 7, 2016. Lab supply companies are eager to meet researchers at this event and discuss with you your research goals. If you are facing problems in the lab, the sales reps at our UC Davis Medical Center show may be able to recommend viable life science solutions.
The University of California, Davis Medical Center is one of the highest funded research institutions in California. The university recently received two new grants from the California Institute for Regenerative Medicine (CIRM), totaling $3.2 million, which will be used to support two research projects focusing on treating cancer and other diseases.Read More
Tags: CA, University of California Davis Medical Center, Southwest, UCDMC, BioResearch Product Faire Event, Sacramento, CIRM, new funding, UC Davis, 2016, California Institutes of Regenerative Medicine
Clostridium difficile, more commonly referred to as C. diff, is a bacteria that makes half a million American's sick each year, and is responsible for over 25,000 deaths annually, both directly and indirectly. The bacteria can lead to serious illnesses in the gut, that can cause diarrhea and colon inflammation. Often times, C. diff infections can be caused by the over use of antibiotics, which affect the healthy bacteria in the gut and provide opportunity for C. diff bacteria to grow in that area.
Researchers from the University of Michigan, Ann Arbor have received a five-year, $9.2 million grant from the National Institute of Allergy and Infectious Diseases to further study C. diff, to learn more about it with the aim of developing new treatment methods. (Image of C. diff bacteria courtesy of Cjc2nd via Wikimedia Commons)Read More
Liver disease and heart disease are two common ailments Americans suffer from. One in ten Americans suffers from liver disease, and heart disease is the leading cause of death in the country. The prominence of these diseases makes them common topics for life science research. Researchers from Rutgers, the State University of New Jersey recently found a connection between an antioxidant and liver and heart disease.Read More
Acute myeloid leukemia (AML) is the most common form of leukemia affecting the blood and bone marrow, and has been responsible for 1.8% of cancer deaths in 2016. Because it is so prevalent, many research teams around the world study this disease in search of new treatment methods. One of these research teams, from Harvard University, has joined up with the pharmaceutical company Merck in a $20 million collaboration to develop new therapeutics for leukemia.Read More